A Comprehensive PvP Analysis on the GBL Season 12 Move Rebalance

Time is short and this is NOT my last article to crank out before GBL Season 12 begins, so let’s just get straight to the point: the first move rebalance, we’ve had in MANY months is finally here, and as expected, it’s a whopper! No bells and whistles… let’s just dive right in! SURF’S UP! BUT […]

GO Battle League Season 14 (Rising Heroes)

A PvP Analysis on the GBL Season 12 Move Rebalance: Part 2! : r/TheSilphArena

ZANUBRUTINIB (ZANU) VERSUS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT‐NAïVE (TN) CLL/SLL: EXTENDED FOLLOW‐UP OF THE SEQUOIA STUDY - Shadman - 2023 - Hematological Oncology - Wiley Online Library

Effect of Galcanezumab on Total Pain Burden in Patients Who Had Previously Not Benefited from Migraine Preventive Medication (CONQUER Trial): A Post Hoc Analysis

A PvP Analysis on the GBL Season 12 Move Rebalance: Part II : r/TheSilphRoad

A Comprehensive PvP Analysis on the GBL Season 12 Move Rebalance

Fixed-duration ibrutinib–venetoclax versus chlorambucil–obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial - The Lancet Oncology

SilphThyme Podcast (@SilphThymePod) / X

SilphThyme Podcast (@SilphThymePod) / X

Silph Arena Reddit

A PvP Analysis on the GBL Season 12 Move Rebalance: Part II : r/TheSilphRoad

SilphThyme Podcast (@SilphThymePod) / X

Great League Remix 2.0 PvP Meta / Budget Analysis